EUVIMEDSkopri EUVIMED
Crossref

Inhibitory effects of Gracilaria edulis and Gracilaria salicornia against the MGMT and VEGFA biomarkers involved in the onset and advancement of glioblastoma using in silico and in vitro approaches

Miji Thandaserry Vasudevan, Kaviyaprabha Rangaraj, Ragupathi Ramesh, Sridhar Muthusami, Chandramohan Govindasamy, Muhammad Ibrar Khan, Palanisamy Arulselvan, Bharathi Muruganantham iD

Biotechnology and Applied Biochemistry · 2025

DOI: 10.1002/bab.2657 ↗

At a glance

Journal article in Biotechnology and Applied Biochemistry, 2025. Written by Miji Thandaserry Vasudevan and 7 co-authors. Institution: Department of Biochemistry, Centre for Bioinformatics, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India. Major MEDLINE topics: Glioblastoma, Vascular Endothelial Growth Factor A, DNA Repair Enzymes, DNA Modification Methylases. Cited 2 times so far (Crossref); 74 references. Funded by: Department of Science and Technology, Ministry of Science and Technology, India, Researchers.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Glioblastoma (GBM), an aggressive primary brain tumor originating from glial cells, poses significant treatment challenges due to its rapid growth and invasiveness. The exact mechanisms of GBM's brain damage remain unclear. This study examines primary molecular markers commonly assessed in GBM patients, including brain‐derived neurotrophic factor (BDNF), platelet‐derived growth factor receptor A (PDGFRA), O 6 ‐methylguanine DNA methyltransferase (MGMT), epidermal growth factor receptor (EGFR), and vascular endothelial growth factor A (VEGFA) using computational approaches. The study revealed significant differences ( p ≤ 0.05) in PDGFRA, EGFR, and VEGFA expression rates, which are particularly interesting. Additionally, MGMT and VEGFA showed higher hazard ratios. Expression levels of MGMT and VEGFA were visualized in immune and malignant cells using single‐cell RNA datasets GSE103224 and GSE148842. From a total of 48 compounds in Gracilaria edulis and 86 in Gracilaria salicornia , we identified 15 compounds capable of crossing the blood‐brain barrier. Notably, 2‐tridecanone (binding affinity [BA] = −4.2 kcal/mol; root mean square deviation [RMSD] = 1.479 Å) and decanoic acid, ethyl ester (BA = −4.2 kcal/mol; RMSD = 1.702 Å) from G. edulis interacted with MGMT via hydrogen bonds. The compound alpha‐terpineol interacted with MGMT (BA = −5.7 kcal/mol; RMSD = 0.501 Å) and VEGFA (BA = −4.7 kcal/mol; RMSD = 2.483 Å). Ethanolic and methanolic extracts from G. edulis and G. salicornia demonstrated mild anti‐cell proliferation properties in the GBM LN‐229 cell line, suggesting potential therapeutic benefits. This study highlights the significance of molecular markers and natural compounds in understanding and potentially treating GBM.

Subjects

MeSH terms (MEDLINE)

GlioblastomaVascular Endothelial Growth Factor ADNA Repair EnzymesDNA Modification MethylasesBiomarkers, TumorTumor Suppressor ProteinsBrain NeoplasmsPlant ExtractsComputer SimulationHumansCell Line, TumorEdible SeaweedsGracilaria

Author keywords

G. edulisG. salicornia extractLN‐229 cell lineglioblastoma

Substances

Vascular Endothelial Growth Factor ADNA Repair EnzymesVEGFA protein, humanDNA Modification MethylasesBiomarkers, TumorMGMT protein, humanTumor Suppressor ProteinsPlant Extracts

Authors and institutions

  • Department of Biochemistry, Centre for Bioinformatics, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India.
  • Department of Biotechnology, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India.
  • Department of Biochemistry, Centre for Cancer Research, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India.
  • Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
  • Department of Chemistry, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India.

ORCID profiles: Bharathi Muruganantham

Funding

  • Department of Science and Technology, Ministry of Science and Technology, India
  • Researchers

Cite

APA

Vasudevan, M. T., Rangaraj, K., Ramesh, R., Muthusami, S., Govindasamy, C., Khan, M. I., Arulselvan, P., & Muruganantham, B. (2025). Inhibitory effects of Gracilaria edulis and Gracilaria salicornia against the MGMT and VEGFA biomarkers involved in the onset and advancement of glioblastoma using in silico and in vitro approaches. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2657

Vancouver

Vasudevan MT, Rangaraj K, Ramesh R, Muthusami S, Govindasamy C, Khan MI, et al. Inhibitory effects of Gracilaria edulis and Gracilaria salicornia against the MGMT and VEGFA biomarkers involved in the onset and advancement of glioblastoma using in silico and in vitro approaches. Biotechnology and Applied Biochemistry. 2025. doi:10.1002/bab.2657

BibTeX
@article{Vasudevan2025,
  author = {Vasudevan, Miji Thandaserry and Rangaraj, Kaviyaprabha and Ramesh, Ragupathi and Muthusami, Sridhar and Govindasamy, Chandramohan and Khan, Muhammad Ibrar and Arulselvan, Palanisamy and Muruganantham, Bharathi},
  title = {Inhibitory effects of Gracilaria edulis and Gracilaria salicornia against the MGMT and VEGFA biomarkers involved in the onset and advancement of glioblastoma using in silico and in vitro approaches},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2025},
  doi = {10.1002/bab.2657}
}
Start for free →